Nadia Waheed's most recent trade in Ocular Therapeutix Inc was a trade of 13,861 Common Stock done at an average price of $8.0 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 02 Jun 2025 | 13,861 | 206,805 (0%) | 0% | 8.0 | 111,581 | Common Stock |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 237,000 | 237,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 79,000 | 220,666 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 141,666 | 141,666 (0%) | 0% | 0 | Common Stock |